Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency: A model of lymphoproliferative diseases in immunocompromised patients

H. Nakamine, M. Okano, Y. Taguchi, S. J. Pirruccello, J. R. Davis, Kirk Beisel, K. Kleveland, W. G. Sanger, R. R. Fordyce, D. T. Purtilo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The anatomical distribution, morphology, and clonality, of 'non-Hodgkin's lymphomas' in immunocompromised patients are usually distinctly different from NHL occurring in the general population. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Nature (London) 335:256, 1988 have described lymphoproliferative disease (LPD) of human B cell origin in mice with severe combined immunodeficiency (scid mice) after transfer of human peripheral blood mononuclear cells from Epstein-Barr virus-seropositive individuals. Reported herein is detailed information regarding the morphology, phenotypes, and clonality of LPD lesions in 10 of 18 scid mice that had developed LPD after transfer of peripheral blood mononuclear cells. These lesions were diffuse and monomorphic proliferations of immunoblastoid cells. They were invasive in their growth and often necrotic. Human B cell-related and activation-associated antigens were found on the LPD lesions, although the numbers of cells with the latter antigens were relatively small. Immunofixation electrophoresis for human immunoglobulins in sera of the majority of mice revealed oligoclonal populations, however, phenotypic and cytogenetic analyses showed no definite monoclonality. This scid mouse model is beneficial for understanding the early phases in the pathogenesis of LPD in immunocompromised patients.

Original languageEnglish
Pages (from-to)389-399
Number of pages11
JournalLaboratory Investigation
Volume65
Issue number4
StatePublished - 1991
Externally publishedYes

Fingerprint

Severe Combined Immunodeficiency
Immunocompromised Host
Human Herpesvirus 4
Blood Cells
B-Lymphocytes
Antigens
Cytogenetic Analysis
Non-Hodgkin's Lymphoma
Population
Electrophoresis
Immunoglobulins
Cell Count
Cell Proliferation
Phenotype
Growth
Serum

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency : A model of lymphoproliferative diseases in immunocompromised patients. / Nakamine, H.; Okano, M.; Taguchi, Y.; Pirruccello, S. J.; Davis, J. R.; Beisel, Kirk; Kleveland, K.; Sanger, W. G.; Fordyce, R. R.; Purtilo, D. T.

In: Laboratory Investigation, Vol. 65, No. 4, 1991, p. 389-399.

Research output: Contribution to journalArticle

Nakamine, H. ; Okano, M. ; Taguchi, Y. ; Pirruccello, S. J. ; Davis, J. R. ; Beisel, Kirk ; Kleveland, K. ; Sanger, W. G. ; Fordyce, R. R. ; Purtilo, D. T. / Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency : A model of lymphoproliferative diseases in immunocompromised patients. In: Laboratory Investigation. 1991 ; Vol. 65, No. 4. pp. 389-399.
@article{dd30ed5a57714f858f6ddbb9b7725632,
title = "Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency: A model of lymphoproliferative diseases in immunocompromised patients",
abstract = "The anatomical distribution, morphology, and clonality, of 'non-Hodgkin's lymphomas' in immunocompromised patients are usually distinctly different from NHL occurring in the general population. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Nature (London) 335:256, 1988 have described lymphoproliferative disease (LPD) of human B cell origin in mice with severe combined immunodeficiency (scid mice) after transfer of human peripheral blood mononuclear cells from Epstein-Barr virus-seropositive individuals. Reported herein is detailed information regarding the morphology, phenotypes, and clonality of LPD lesions in 10 of 18 scid mice that had developed LPD after transfer of peripheral blood mononuclear cells. These lesions were diffuse and monomorphic proliferations of immunoblastoid cells. They were invasive in their growth and often necrotic. Human B cell-related and activation-associated antigens were found on the LPD lesions, although the numbers of cells with the latter antigens were relatively small. Immunofixation electrophoresis for human immunoglobulins in sera of the majority of mice revealed oligoclonal populations, however, phenotypic and cytogenetic analyses showed no definite monoclonality. This scid mouse model is beneficial for understanding the early phases in the pathogenesis of LPD in immunocompromised patients.",
author = "H. Nakamine and M. Okano and Y. Taguchi and Pirruccello, {S. J.} and Davis, {J. R.} and Kirk Beisel and K. Kleveland and Sanger, {W. G.} and Fordyce, {R. R.} and Purtilo, {D. T.}",
year = "1991",
language = "English",
volume = "65",
pages = "389--399",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency

T2 - A model of lymphoproliferative diseases in immunocompromised patients

AU - Nakamine, H.

AU - Okano, M.

AU - Taguchi, Y.

AU - Pirruccello, S. J.

AU - Davis, J. R.

AU - Beisel, Kirk

AU - Kleveland, K.

AU - Sanger, W. G.

AU - Fordyce, R. R.

AU - Purtilo, D. T.

PY - 1991

Y1 - 1991

N2 - The anatomical distribution, morphology, and clonality, of 'non-Hodgkin's lymphomas' in immunocompromised patients are usually distinctly different from NHL occurring in the general population. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Nature (London) 335:256, 1988 have described lymphoproliferative disease (LPD) of human B cell origin in mice with severe combined immunodeficiency (scid mice) after transfer of human peripheral blood mononuclear cells from Epstein-Barr virus-seropositive individuals. Reported herein is detailed information regarding the morphology, phenotypes, and clonality of LPD lesions in 10 of 18 scid mice that had developed LPD after transfer of peripheral blood mononuclear cells. These lesions were diffuse and monomorphic proliferations of immunoblastoid cells. They were invasive in their growth and often necrotic. Human B cell-related and activation-associated antigens were found on the LPD lesions, although the numbers of cells with the latter antigens were relatively small. Immunofixation electrophoresis for human immunoglobulins in sera of the majority of mice revealed oligoclonal populations, however, phenotypic and cytogenetic analyses showed no definite monoclonality. This scid mouse model is beneficial for understanding the early phases in the pathogenesis of LPD in immunocompromised patients.

AB - The anatomical distribution, morphology, and clonality, of 'non-Hodgkin's lymphomas' in immunocompromised patients are usually distinctly different from NHL occurring in the general population. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Nature (London) 335:256, 1988 have described lymphoproliferative disease (LPD) of human B cell origin in mice with severe combined immunodeficiency (scid mice) after transfer of human peripheral blood mononuclear cells from Epstein-Barr virus-seropositive individuals. Reported herein is detailed information regarding the morphology, phenotypes, and clonality of LPD lesions in 10 of 18 scid mice that had developed LPD after transfer of peripheral blood mononuclear cells. These lesions were diffuse and monomorphic proliferations of immunoblastoid cells. They were invasive in their growth and often necrotic. Human B cell-related and activation-associated antigens were found on the LPD lesions, although the numbers of cells with the latter antigens were relatively small. Immunofixation electrophoresis for human immunoglobulins in sera of the majority of mice revealed oligoclonal populations, however, phenotypic and cytogenetic analyses showed no definite monoclonality. This scid mouse model is beneficial for understanding the early phases in the pathogenesis of LPD in immunocompromised patients.

UR - http://www.scopus.com/inward/record.url?scp=0025788061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025788061&partnerID=8YFLogxK

M3 - Article

C2 - 1656139

AN - SCOPUS:0025788061

VL - 65

SP - 389

EP - 399

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 4

ER -